Medicins Sans Frontiers Files to Block Pfizer Patent on Pneumonia Vaccine in India

March 11, 2016

(Reuters) – The charity Medicins Sans Frontieres has formally opposed U.S. firm Pfizer Inc’s application for an Indian patent on a highly effective pneumonia vaccine, saying it could deprive many developing nations of cheaper copies of the drug. Some of the world’s poorest countries and medical charities such as Medecins Sans Frontieres (MSF) depend on India’s robust pharmaceutical industry to make cheaper forms of drugs and vaccines developed by big Western pharmaceutical companies such as Pfizer.

The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.